公司业绩与股价表现 - 公司9月股价强劲上涨10% [2] - 核心产品Rinvoq在2024年销售额超过13亿美元，占公司总收入的11% [4] 核心产品进展 - 公司与所有仿制药制造商就Rinvoq的仿制申请达成协议，将Rinvoq的市场独占权延长至2037年4月 [3][4] - Rinvoq是一种经FDA批准用于多种适应症的广谱抗炎药，是公司的顶级销售产品 [4] 研发管线进展 - 针对侵袭性血癌的研究药物pivekimab sunirine (PVEK)已向FDA提交生物制剂许可申请(BLA)，目前正在审批中 [5] - 针对帕金森病的口服药物tavapadon已向FDA提交新药申请(NDA) [6] 生产能力与设施扩张 - 公司启动位于马萨诸塞州的AbbVie生物研究中心的扩建工程，投资金额为7000万美元 [8] - 扩建将加强生物制剂的生产能力以及研究和办公空间 [8]

Johnson & Johnson (NYSE:JNJ) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Johnson & Johnson (JNJ): A Cornerstone Among the Most Profitable Dividend Stocks Johnson & Johnson (NYSE:JNJ) is one of America’s most recognizable healthcare companies, with operations that now center on pharmaceuticals and medical devices. After spinning off its consumer health unit, which included familiar names like Tylenol, Neutrogena, and Listerine, into a separate company called Kenvue, the comp ...

These two market leaders have increased their dividends for a combined 115 years.It's impossible to predict with certainty whether a recession is coming, but certain developments sure make it more likely. President Donald Trump's tariff policies could lead to increased prices and plunge the economy into a downturn. The recent government shutdown, especially if it drags on, could lead us directly into a recession.Of course, that may not happen, but it's not a bad idea for investors to prepare for that possib ...

ConversationD. WalkeSenior Vice President of Investor Relations Good morning, and welcome, everyone, to Ionis Pharmaceuticals 2025 Innovation Day. I'm Wade Walke, Head of Investor Relations. And it's great to see so many of you here in the room with us today. We'd also like to welcome those who are joining us today online via our webcast. Every 2 years, we host this meeting in order to give you an update on the progress we're making on our goal to transform the lives of people with unmet -- severe unmet me ...

强生控股 - 公司是数据中心产业链的关键组成部分 提供电气组件等产品 [1] 制药行业 - 大型制药公司领域存在投资价值 可通过PPH交易所交易基金进行投资 [1] 住宅建筑行业 - 行业虽遭普遍下调评级 但不应全盘否定 仍存在选择性机会 [2] - Toll Brothers公司定位高端财富客户 其客户更可能全款购房 被认为是行业内值得关注的对象 [2] IBM公司 - 公司被认为是投资人工智能和量子计算的低调标的 但其价值未得到市场充分认可 [2]

Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement TermsOctober 07, 2025 5:48 PM EDT | Source: Genix Pharmaceuticals Corp.Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") wishes to clarify an error in its news release dated September 04, 2025, regarding the Company's recently closed non-brokered private placement.The previous release incorrectly stated that the Units wer ...

WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it will be presenting both an oral presentation and a poster on VP-315, its oncolytic peptide for the treatment of basal cell carcinoma (BCC), at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting taking place November 5–9, 2025, in National Ha ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients – and it's exactly what President Donald Trump wants. Amgen is the latest company to wade into the direct-to-consumer space, announcing on Monday that it will offer its cholesterol-lowering drug Repatha at a cash price 60% bel ...

Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly , STAT News reported on Tuesday. ...

Key Takeaways Amgen launched AmgenNow, offering direct discounts starting with its cholesterol drug Repatha.Repatha's new $239 monthly price marks a nearly 60% cut from its U.S. list price.Amgen partnered with GoodRx to make Repatha available at this price across 70,000 pharmacies.Amgen (AMGN) announced the launch of a new direct-to-consumer (DTC) program called AmgenNow, which will offer significant discounts on its marketed drugs. The company has initiated this DTC program with its blockbuster cholesterol ...